. . . "Fungi, yeast and protozoans"@en . . . "Compositenst\u00E4rke"@en . . "Butoconazole"@en . . . "Alant starch"@en . "Butoconazolum"@en . "For the local treatment of vulvovaginal candidiasis (infections caused by Candida)"@en . . . . . . . . . . . . . . "Laszlo Czibula, Laszlo Dobay, Eva Werkne Papp, Judit Nagyne Bagdy, Ferenc Sebok, \"High Purity Butoconazole Nitrate with Specified Particle Size and a Process for the Preparation Thereof.\" U.S. Patent US20080221190, issued September 11, 2008."@en . . . . . "Oral, rat: LD₅₀ = >1720 mg/kg."@en . . . "Dahlin"@en . . . . "approved"@en . . "The exact mechanism of the antifungal action of butoconazole is unknown, however, it is presumed to function as other imidazole derivatives via inhibition of steroid synthesis. Imidazoles generally inhibit the conversion of lanosterol to ergosterol via the inhibition of the enzyme cytochrome P450 14α-demethylase, resulting in a change in fungal cell membrane lipid composition. This structural change alters cell permeability and, ultimately, results in the osmotic disruption or growth inhibition of the fungal cell."@en . . . . . "Butoconazol"@en . "Butoconazole is an imidazole antifungal used in gynecology."@en . . . . . . . . "1-[4-(4-Chloro-phenyl)-2-(2,6-dichloro-phenylsulfanyl)-butyl]-1H-imidazole"@en . . . " "@en . . "Following vaginal administration of butoconazole nitrate vaginal cream, 2% to 3 women, 1.7% (range 1.3-2.2%) of the dose was absorbed on average."@en . . . . . " "@en . . "Butoconazole"@en . . . . . . "Polyfructosanum"@en . . . . "64872-77-1"@en . .